Stent for Life Initiative placed at the forefront in Egypt 2011

EuroIntervention

Volumn 8, Issue , 2012, Pages P108-P115

  Sobhy, Mohamed ^a   Sadaka, Mohamed ^a   Okasha, Nireen ^b   Farag, El Sayed ^c   Saleh, Ayman ^b   Ismail, Hussein ^d   Seteiha, Mohamed El ^e   Ragy, Hany ^f   Hameed, Mohamed Abdel ^a   Mehanna, Radwa ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c ZAGAZIG UNIVERSITY   (Egypt)

^d Suez Canal University Faculty of Medicine   (Egypt)

^e TANTA UNIVERSITY   (Egypt)

^f HEART INSTITUTE   (Egypt)

Author keywords

Myocardial infarction; Primary PCI; STEMI

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE REGISTRY; DYSLIPIDEMIA; EGYPT; EMERGENCY HEALTH SERVICE; FEMALE; HOSPITAL MORTALITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTOR; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT FOR LIFE REGISTRY; THROMBUS ASPIRATION; DRUG ELUTING STENT; EQUIPMENT; HEALTH CARE DELIVERY; HEART INFARCTION; HOSPITAL PLANNING; INTEGRATED HEALTH CARE SYSTEM; MIDDLE AGED; MORTALITY; NONBIOLOGICAL MODEL; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; PROSTHESIS; REGISTER; STANDARD; STENT; TIME; TIME TO TREATMENT; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

METAL;

ADULT; AGED; AGED, 80 AND OVER; DELIVERY OF HEALTH CARE, INTEGRATED; DRUG-ELUTING STENTS; EGYPT; FEMALE; HEALTH SERVICES ACCESSIBILITY; HOSPITAL MORTALITY; HOSPITAL PLANNING; HUMANS; MALE; METALS; MIDDLE AGED; MODELS, ORGANIZATIONAL; MYOCARDIAL INFARCTION; ORGANIZATIONAL OBJECTIVES; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINES AS TOPIC; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; PROSTHESIS DESIGN; REGISTRIES; RISK FACTORS; STENTS; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904823690     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV8SPA19     Document Type: Article

References (19)

1. Robert Beaglehole. The World Health Organization Report 2004.
2. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104:2158-63.
3. St. Agnes Healthcare. Early Heart Attack Care. Retrieved November 29, 2006.
4. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA. 2000;28:2686-92.
5. Rokos IC, Larson DM, Henry TD, Koenig WJ, Eckstein M, French WJ, Granger CB, Roe MT. Rationale for establishing regional ST-elevation myocardial infarction receiving center (SRC) networks. Am Heart J. 2006;152:661-7.
6. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987;76:142-54.
7. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574-e651.
8. ACCESS Investigators. Management of acute coronary syndromes in developing countries:Acute coronary events-a multinational survey of current management strategies. Am Heart J. 2011; 162:852-859.e22
9. Kristensen SD, Laut KG, Kaifoszova Z, Widimsky P. Variable penetration of primary angioplasty in Europe-what determines the implementation rate? EuroIntervention. 2012;8:35-42.
10. Rasoul S, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Zijlstra F, Suryapranata H, van't Hof AW; Zwolle Myocardial Infarction Study Group. Primary percutaneous coronary intervention for STEMI: from clinical trial to clinical practice. Int J Cardiol. 2009;134:104-9.
11. Jafary FH, Arham AZ, Waqar F, Raza A, Ahmed H. Survival of patients receiving fibrinolytic therapy for acute ST-segment elevation myocardial infarction in a developing country-patient characteristics and predictors of mortality. J Thromb Thrombolysis. 2008; 26:147-9.
12. Juwana YB, Wirianta J, Ottervanger JP, Dambrink JH, van 't Hof AW, Gosselink AT, Hoorntje J, de Boer MJ, Suryapranata H. Primary coronary intervention for ST-elevation myocardial infarction in Indonesia and the Netherlands: a comparison. Neth Heart J. 2009;17:418-21.
13. Sutton AG, Campbell PG, Graham R, Price DJ, Gray JC, Grech ED, Hall JA, Harcombe AA, Wright RA, Smith RH, Murphy JJ, Shyam-Sundar A, Stewart MJ, Davies A, Linker NJ, de Belder MA. A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial. J Am Coll Cardiol. 2004;44:287-96.
14. Pedersen S, Galatius S, Mogelvang R, Davidsen U, Galloe A, Abildstrom SZ, Abildgaard U, Hansen PR, Bech J, Iversen A, Jorgensen E, Kelbaek H, Saunamaki K, Madsen JK, Jensen JS. Long-term prognosis in an ST-segment elevation myocardial infarction population treated with routine primary percutaneous coronary intervention: from clinical trial to real-life experience. Circ Cardiovasc Interv. 2009;2:392-400.
15. Busk M, Maeng M, Rasmussen K, Kelbaek H, Thayssen P, Abildgaard U, Vigholt E, Mortensen LS, Thuesen L, Kristensen SD, Nielsen TT, Andersen HR; DANAMI-2 Investigators. The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up. Eur Heart J. 2008; 29:1259-66.
16. Abdessalem S, Mjadlah S, Mahjoub H, Mourali S, Mechemeche R. Immediate and 12-month outcomes of an interventional reperfusion strategy in acute STEMI. Report of 208 successive patients. Tunis Med. 2009;87:755-62.
17. Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L, Andrikopoulos G, Baz JA, Betriu A, Claeys M, Danchin N, Djambazov S, Erne P, Hartikainen J, Huber K, Kala P, Klinceva M, Kristensen SD, Ludman P, Ferre JM, Merkely B, Milicic D, Morais J, Noc M, Opolski G, Ostojic M, Radovanovic D, De Servi S, Stenestrand U, Studencan M, Tubaro M, Vasiljevic Z, Weidinger F, Witkowski A, Zeymer U; European Association for Percutaneous Cardiovascular Interventions. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries". Eur Heart J. 2010; 31:943-57.
18. Gershlick AH, Stephens-Lloyd A, Hughes S, Abrams KR, Stevens SE, Uren NG, de Belder A, Davis J, Pitt M, Banning A, Baumbach A, Shiu MF, Schofield P, Dawkins KD, Henderson RA, Oldroyd KG, Wilcox R; REACT Trial Investigators. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med. 2005;353:2758-68.
19. Shavelle DM, Salami A, Abdelkarim M, French WJ, Shook TL, Mayeda GS, Burstein S, Matthews RV. Rescue percutaneous coronary intervention for failed thrombolysis. Catheter Cardiovasc Interv. 2006; 67:214-20.